S99.139S Salter-Harris Type III physeal fracture of unspecified metatarsal, sequela

Name of the Condition

• Salter-Harris Type III physeal fracture of unspecified metatarsal, sequela

Summary

This condition represents a Salter-Harris Type III physeal fracture of an unspecified metatarsal bone in the foot, classified as a sequela. Type III fractures involve a fracture line extending through the growth plate (physis) and into the epiphysis, potentially disrupting the joint surface. Sequela indicates this is a residual effect or complication following the initial injury, requiring ongoing management to address long-term consequences.

Causes

The sequela arises from a prior Salter-Harris Type III physeal fracture of the metatarsal. The original injury typically resulted from direct trauma, such as falls, sports-related impacts, or accidents, which disrupted the growth plate. The sequela reflects persistent effects of the initial fracture, including malunion, growth disturbance, or chronic pain.

Risk Factors

• Age: Children and adolescents, as their growth plates are still developing and more susceptible to injury.
• High-impact activities: Participation in sports like running, jumping, or contact sports.
• Previous injuries: Prior damage to the metatarsals or surrounding structures may increase vulnerability.

Symptoms

• Chronic pain or discomfort in the metatarsal area.
• Limited range of motion or stiffness in the affected foot.
• Visible deformity or malalignment of the metatarsal.
• Difficulty bearing weight or walking on the affected foot.
• Possible joint dysfunction or arthritis-like symptoms.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including patient history of the original injury and current symptoms. Physical examination assesses for deformity, tenderness, or functional limitations. Imaging studies, such as X-rays or MRI, may be used to evaluate the extent of residual damage, including malunion, growth plate disturbance, or joint involvement. The sequela classification confirms the condition is a long-term consequence of the prior fracture.

Treatment Options

Treatment focuses on managing symptoms and addressing residual effects. Options may include:

• Pain management with medications or physical therapy.
• Orthotic devices or braces to support the foot and improve function.
• Surgical intervention in cases of severe malunion or joint disruption.
• Rehabilitation to restore mobility and strength.

Prognosis and Follow-Up

Prognosis depends on the severity of the sequela and the effectiveness of treatment. Some patients may experience persistent symptoms, while others achieve improved function with intervention. Regular follow-up is essential to monitor for complications, such as growth abnormalities or arthritis, and adjust treatment as needed.

Complications

• Chronic pain or discomfort.
• Growth plate disturbance leading to limb length discrepancy.
• Joint stiffness or arthritis.
• Malunion or deformity of the metatarsal.
• Reduced mobility or functional limitations.

Lifestyle & Prevention

• Avoid high-impact activities that stress the foot.
• Use proper footwear and protective gear during sports.
• Maintain a healthy weight to reduce stress on the feet.
• Follow post-injury rehabilitation protocols to minimize long-term effects.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new pain or deformity develops, or functional limitations increase. Prompt evaluation is necessary to address complications and adjust treatment plans.

Tips for Medical Coders

This code (S99.139S) is used for a Salter-Harris Type III physeal fracture of an unspecified metatarsal, classified as a sequela. Documentation should clearly indicate the residual effects of the prior fracture, including symptoms, functional limitations, or imaging findings confirming the sequela. Ensure the code aligns with the patient's current condition and prior injury history.